Home » Topics » BioWorld Science

BioWorld Science
RSS

Pivotal phase III study of Qzytir in acute urticaria meets key endpoints

June 26, 2018

EMA validates Giapreza MAA

June 26, 2018

Aurinia expands voclosporin clinical development program

June 26, 2018

Phase Ib trial results for enzalutamide/CC-115 for metastatic castration-resistant prostate cancer

June 26, 2018

Biktarvy approved in Europe for the treatment of HIV-1 infection

June 26, 2018

Aerpio and Gossamer Bio enter exclusive license agreement for AKB-4924

June 26, 2018

Phase III EASE-2 and EASE-3 trials of empagliflozin in type 1 diabetes meet primary endpoint

June 26, 2018

Ribomic submits IND for anti-FGF-2 candidate

June 26, 2018

CellCentric initiates first-in-man study of CCS-1477 for late-stage prostate cancer

June 25, 2018

Merrimack discontinues development of MM-141 for pancreatic cancer following CARRIE results

June 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...